ArticleThe Prostate2021

The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer.

Zhipeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.